EcoDrugPlus

Janus Kinase 1

Ensembl ID : ENSMZEG00005014405
Gene Symbol: JAK1
3 Cross references
212 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSMZEG00005017913
Gene Symbol: KRAS
3 Cross references
207 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSMZEG00005000948
Gene Symbol: MAPKAPK2
3 Cross references
187 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSMZEG00005008431
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSMZEG00005018927
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSMZEG00005021557
Gene Symbol: MDM2
3 Cross references
275 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSMZEG00005013436
Gene Symbol: MET
3 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSMZEG00005007814
Gene Symbol: MLST8
3 Cross references
198 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSMZEG00005028504
Gene Symbol: NAALAD2
1 Cross references
335 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1

Ensembl ID : ENSMZEG00005002743
Gene Symbol: LOC106675519
3 Cross references
182 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1

Ensembl ID : ENSMZEG00005002686
Gene Symbol: LOC106675515
3 Cross references
184 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSMZEG00005023671
Gene Symbol: NOX4
4 Cross references
150 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).